Morality on the march in the healthcare community: Is it time for medical marketers to find out more about healthcare ethics?

Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing

Volumn 3, Issue 4, 2003, Pages 327-333

  Phillips, Steffan ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

bioethics; clinical ethics committees; ethics; healthcare; NICE; No Free Lunch

Indexed keywords

EID: 84990334723     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5040134     Document Type: Article

References (12)

1. The Association of the British Pharmaceutical Industry (ABPI) (2001) Code of Practice for the Pharmaceutical Industry.
2. Singer P. (1994) Ethics. Oxford University Press, Oxford.
3. Hawthorne F. (2003) The Merck Druggernaut. John Wiley & Sons, New Jersey.
4. The Merck Druggernaut.
5. Beauchamp T.L. Childress J.F. (1994) Principles of Biomedical Ethics, 4th edn. Oxford, Oxford University Press.
6. Phillips C. ‘So what is a QALY?’ www.jr2.ox.ac.uk/bandolier/band24/b24-7.html.
7. Baines D. (2003) ‘Balancing act’, Pharmaceutical Marketing, 14(11), 22–23.
8. Press release from ACCC on pharmaceutical promotion www.essentialdrugs.org/edrug/archive/200306/msg00069.php.
9. le Carré J. (2001) The Constant Gardener. Hodder and Stoughton, London.
10. BMJ (2003) 326 (7400), http://bmj.com/content/vol326/issue7400/.
11. Abbasi K. Smith R. (2003) ‘No more free lunches’, BMJ, 326 (7400).
12. Elling M.E. Fogle H.J. McKhann C.S. Simon C. (2002) ‘Making more of pharma's sales force’, www.mckinseyquarterly.com.